EPC-K1, a hydroxyl radical scavenger, prevents 6-hydroxydopamine-induced dopamine depletion in the mouse striatum by up-regulation of catalase activity

Neurochemical Research

Volumn 24, Issue 12, 1999, Pages 1543-1548

  Kabuto, Hideaki ^a   Yokoi, Isao ^b   Iwata Ichikawa, Emi ^b   Ogawa, Norio ^b  

^a KAGAWA PREFECTURAL UNIVERSITY OF HEALTH SCIENCES   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

6 Hydroxydopamine; Catalase; Dopamine; EPC K1; Radical scavenger

Indexed keywords

4 HYDROXYNONENAL; ASCORBIC ACID 2 [3,4 DIHYDRO 2,5,7,8 TETRAMETHYL 2 (4,8,12 TRIMETHYLTRIDECYL) 2H 1 BENZOPYRAN 6 YL HYDROGEN PHOSPHATE] POTASSIUM; CATALASE; DOPAMINE; GLUTATHIONE; HYDROXYL RADICAL; MALONALDEHYDE; OXIDOPAMINE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; ENZYME ACTIVITY; MALE; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

ANIMALIA;

EID: 0032721206     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021152115752     Document Type: Article

References (29)

1. Andrew, R., Watson, D. G., Best, S. A., Midgey, H., Wenlong, H., and Petty, R. K. H. 1993. The determination of hydroxydopamines and other trace amines in the urine of Parkinsonian patients and normal controls. Neurochem. Res. 18:1175-1177.
2. Kondo, T. 1996. Parkinson's disease and free radicals. Mechanism of neurodegeneration and neuroprotection. Ann. N. Y. Acad. Sci. 786:206-216.
3. Glinka, Y., Gassen, M., and Youdim, M. B. H. 1997. Mechanism of 6-hydroxydopamine neurotoxicity. J. Neural. Transm. Suppl. 50:55-66.
4. Kumar, R., Agarwal, A. K., and Seth, P. K. 1995. Free radical-generated neurotoxicity of 6-hydroxydopamine. J. Neurochem. 64:1703-1707.
5. Weisiger, R. A., and Fridovich, I. 1973. Superoxide dismutase: organelle specificity. J. Biol. Chem. 248:3582-3592.
6. Riederer, P., Sofic, E., Rausch, W. D., Schmidt, B., Reynolds, G. P., Jellinger, K., Youdim., and M. B. H. 1989. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52:515-520.
7. Sian, J., Dexter, D. T., Lees, A. J., Daniel, S. E., Agid, Y., Javoy-Agid, F., Jenner, P., and Marsden, C. D. 1994. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting the basal ganglia. Ann. Neurol. 36:348-355.
8. Marshall, K. A., Reiter, R. J., Poeggeler, B., Aruoma, O. I., and Halliwell, B. 1996. Evaluation of the antioxidant activity of melatonin in vitro. Free Rad. Biol. Med. 21:307-315.
9. Reiter, R. J., Tan, D. X., Poeggeler, B., Menendez, P. A., Chen, L. D., and Saarela, S. 1994. Melatonin as a free radical scavenger: implications for aging and age-related diseases. Ann. N.Y. Acad. Sci. 719:1-12.
10. Kim, Y. S., Joo, W. S., Jin, B. K., Cho, Y. H., Baik, H. H., and Park, C. W. 1998. Melatonin protects 6-OHDA-induced neuronal death of nigrostriatal dopaminergic system. NeuroReport 9:2387-2390.
11. Packer, L., and Landvik, S. 1990. Vitamin E in biological systems. Adv. Exp. Med. Biol. 264:93-103.
12. Cadet, J. L., Katz, M., Jackson-Lewis, V., and Fahn, S. 1989. Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence. Brain Res. 476:10-15.
13. Odunze, I. N., Klaidman, L. K., and Adams, J. D. Jr. 1990. MPTP toxicity in the mouse brain and vitamin E. Neurosci. Lett. 108:346-349.
14. Fahn, S. 1992. A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease. Ann. Neurol. Suppl. 32: 128-132.
15. Kuribayashi, Y., Yoshida, K., Sakuue, T., and Okuma, A. 1992. In vitro studies on the influence of L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)2H-1-benzopyran- 6yl-hydrogen phosphate] potassium salt on lipid peroxidation and phosphate A2 activity. Arzneimittelforschung / Drug Res. 42:1072-1074.
16. Block, F., Kunkel, M., and Sontag, K. H. 1995. Posttreatment with EPC-K1, an inhibitor of lipid peroxidation and of phospholipase A2 activity, reduces functional deficits after global ischemia in rats. Brain Res. Bull. 36:257-60.
17. Janero, D. R. 1990. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic. Biol. Med. 9:515-540.
18. Esterbauer, H., Schaur, R. J., and Zollner, H. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11:81-128.
19. Oberley, L. W., and Spitz, D. R. 1984. Assays of superoxide dismutase activity in tumor tissue. Methods Enzymol. 105: 457-464.
20. Aebi, H. 1974. Catalase. Methods of Enzymatic Analysis vol. II, 673-684, Academic Press.
21. Tietze, F. 1969. Enzymic method for quantitave determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissue. Anal. Biochem. 27:502-522.
22. Buege, J. A., and Aust, S. D. 1978. Microsomal lipid peroxidation. In: Fleisher, S. and Packer, L. eds. Methods Enzymol. New York: Academic Press. 302-310.
23. Esterbauer, H., and Cheeseman, K. H. 1990. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186:407-421.
24. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein dye binding. Anal. Biochem. 72:248-254.
25. Glinka, Y., and Youdim, M. B. H. 1995. Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. Eur. J. Pharmacol. Environ. Toxicol. Pharmacol. 292:329-332.
26. Yokoi, I., Kabuto, H., Yamamoto, M., and Mori, A. 1990. Effect of ferric ion and active oxygen scavenger on monoamine release in the striatum of the rat. Jpn. J. Psychiatr. Neurol. 44:440-441.
27. Double, K. L., Maywald, M., Schmittel, M., Riederer, P., and Gerlach, M. 1998. In vitro studies of ferritin iron release and neurotoxicity. J. Neurochem. 70:2492-2499.
28. Vroegop, S. M., Decker, D. E., and Buxser, S. E. 1995. Localization of damage induced by reactive oxygen species in cultured cells. Free Radic. Biol. Med. 18:141-151.
29. Yamada, K., Umegaki, H., Maezawa, I., Iguchi, A., Kameyama, T., and Nabeshima, T. 1997. Possible involvement of catalase in the protective effect of interleukin-6 against 6-hydroxydopamine toxicity in PC12 cells. Brain Res. Bull. 43: 573-577.